News
An influx of illegal vapes that are appealing to children and teens has been making its way into the U.S. from China, FDA ...
Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that ...
The FDA's assessment of the bread recall has designated it as a Class II risk, which means the product "may cause temporary ...
Taking medication for an allergic reaction? You might face severely itchy skin as a side effect of Zyrtec or Xyzal, according ...
FDA Commissioner Dr. Marty Makary joins Morning Joe to address the agency’s controversial decision to keep Juul e-cigarettes ...
The Food and Drug Administration (FDA) has been busy lately with various recalls. One involved Power Stick deodorant and ...
Explore more
A Food and Drug Administration (FDA) expert panel has reignited a debate over whether hormone therapy should be used to treat ...
The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...
An FDA advisory panel concludes that the efficacy of brexpiprazole, when started concurrently with sertraline, has not been ...
The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program. Dr.
George Tidmarsh, a Stanford University physician who founded Horizon Pharma and later ran La Jolla Pharma, was named head of ...
The U.S. Food and Drug Administration said on Monday it has appointed George Tidmarsh, a seasoned biotech executive and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results